Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
about
Pneumococcal vaccines for sickle cell diseaseSafety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure dataDrug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants.Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.Pneumococcal conjugate vaccines: emerging clinical information and its implications.The Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.Development and clinical evaluation of Prevnar 13, a 13-valent pneumocococcal CRM197 conjugate vaccine.Epilepsy and vaccinations: Italian guidelines.Safety and tolerability of pneumococcal vaccines in children.Injection Site Lichenoid Dermatitis Following Pneumococcal Vaccination: Report and Review of Cutaneous Conditions Occurring at Vaccination Sites.Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).Immune-complex-like disease in the course of Enterobacter cloacae sepsis due to cholelithic cholecystitis preceded by influenza vaccination.Pneumococcal Vaccines - How Many Serotypes are Enough?
P2860
Q24247418-3A0DF157-E6A2-44A7-8087-6DFFFFBFA004Q31158788-F98B38F7-F5DE-4C55-8069-20384CCD03C7Q33398833-2BD787F5-0C89-4F27-AD36-69CCA01E939FQ33418883-96000897-864B-4D29-9E4F-04A0D9F5D0B5Q33940618-32AC8ADB-864A-4A3B-B154-81D4CBD1ABB1Q34590621-05335CDD-D454-43E8-A3F0-24C96011EB07Q36600371-29428CA6-2ABF-47DB-96F9-DEFF308CDB28Q36713715-A0C2DE31-0D83-49CB-93C6-BAC40DECFE6FQ37077655-0E1A7AB2-69B3-44E9-B7E5-96A3272EBE7BQ37622887-A0E5E194-0274-4E2B-B8E8-92F2E0ADC603Q37908267-C914FFA6-A4EE-4A28-8671-4EB462761C01Q38029384-611A3DB0-EB24-4689-88D7-2949531F33E2Q38149917-BB13FA94-8096-4ACC-9946-D77B50E38101Q38753554-ECFDBC3A-1FD0-4E1C-9BDA-EDEE88AA39C8Q38779212-5C54C810-9699-4422-8449-F8DD53C30AF2Q39939000-B80D7468-17CB-4C32-B5E0-3591BE1E0A4AQ50175196-57D3BBA5-565E-48E0-B85B-488DBB6D4A92Q50192579-041BE596-3505-467E-A122-91742771F1D5
P2860
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@ast
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@en
type
label
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@ast
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@en
prefLabel
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@ast
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@en
P2093
P356
P1476
Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine.
@en
P2093
John Iskander
M Miles Braun
R Douglas Pratt
Robert Ball
Robert P Pless
Robert P Wise
Scott Campbell
P304
P356
10.1001/JAMA.292.14.1702
P407
P577
2004-10-01T00:00:00Z